Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G. Langley, . . . Hidemi Nakagawa. (2023). Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Adis, Springer Healthcare.
Chicago Style (17th ed.) CitationAkihiko Asahina, et al. Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Adis, Springer Healthcare, 2023.
MLA (9th ed.) CitationAkihiko Asahina, et al. Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Adis, Springer Healthcare, 2023.
Warning: These citations may not always be 100% accurate.